A citation-based method for searching scientific literature

Rickinder Sethi, Nieves Gómez-Coronado, Adam J Walker, Oliver D'Arcy Robertson, Bruno Agustini, Michael Berk, Seetal Dodd. Front Psychiatry 2019
Times Cited: 23







List of co-cited articles
88 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy.
Paula Kopschina Feltes, Janine Doorduin, Hans C Klein, Luis Eduardo Juárez-Orozco, Rudi Ajo Dierckx, Cristina M Moriguchi-Jeckel, Erik Fj de Vries. J Psychopharmacol 2017
92
21

From inflammation to sickness and depression: when the immune system subjugates the brain.
Robert Dantzer, Jason C O'Connor, Gregory G Freund, Rodney W Johnson, Keith W Kelley. Nat Rev Neurosci 2008
21

Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies.
C A Köhler, T H Freitas, M Maes, N Q de Andrade, C S Liu, B S Fernandes, B Stubbs, M Solmi, N Veronese, N Herrmann,[...]. Acta Psychiatr Scand 2017
461
17

A meta-analysis of cytokines in major depression.
Yekta Dowlati, Nathan Herrmann, Walter Swardfager, Helena Liu, Lauren Sham, Elyse K Reim, Krista L Lanctôt. Biol Psychiatry 2010
17

A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
Charles L Raison, Robin E Rutherford, Bobbi J Woolwine, Chen Shuo, Pamela Schettler, Daniel F Drake, Ebrahim Haroon, Andrew H Miller. JAMA Psychiatry 2013
883
13


Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study.
Seyed-Hesameddin Abbasi, Fahimeh Hosseini, Amirhossein Modabbernia, Mandana Ashrafi, Shahin Akhondzadeh. J Affect Disord 2012
191
13


Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial.
Shahin Akhondzadeh, Sara Jafari, Firoozeh Raisi, Abbas Ali Nasehi, Aboulfazl Ghoreishi, Bahman Salehi, Soodeh Mohebbi-Rasa, Maedeh Raznahan, Abbas Kamalipour. Depress Anxiety 2009
239
13


The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.
N Müller, M J Schwarz, S Dehning, A Douhe, A Cerovecki, B Goldstein-Müller, I Spellmann, G Hetzel, K Maino, N Kleindienst,[...]. Mol Psychiatry 2006
516
13


Prostaglandins and inflammation.
Emanuela Ricciotti, Garret A FitzGerald. Arterioscler Thromb Vasc Biol 2011
13

Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials.
Ole Köhler, Michael E Benros, Merete Nordentoft, Michael E Farkouh, Rupa L Iyengar, Ole Mors, Jesper Krogh. JAMA Psychiatry 2014
457
13



Inflammation and clinical response to treatment in depression: A meta-analysis.
R Strawbridge, D Arnone, A Danese, A Papadopoulos, A Herane Vives, A J Cleare. Eur Neuropsychopharmacol 2015
301
8

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
M Bryant Howren, Donald M Lamkin, Jerry Suls. Psychosom Med 2009
8

Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis.
Cristiano A Köhler, Thiago H Freitas, Brendon Stubbs, Michael Maes, Marco Solmi, Nicola Veronese, Nayanna Q de Andrade, Gerwyn Morris, Brisa S Fernandes, André R Brunoni,[...]. Mol Neurobiol 2018
186
8

Treatment-resistant depression and peripheral C-reactive protein.
Samuel R Chamberlain, Jonathan Cavanagh, Peter de Boer, Valeria Mondelli, Declan N C Jones, Wayne C Drevets, Philip J Cowen, Neil A Harrison, Linda Pointon, Carmine M Pariante,[...]. Br J Psychiatry 2019
114
8


Increased xanthine oxidase in the thalamus and putamen in depression.
Tanja Maria Michel, Sybille Camara, Thomas Tatschner, Sophia Frangou, Abigail Jane Sheldrick, Peter Riederer, Edna Grünblatt. World J Biol Psychiatry 2010
48
8

Immune mechanisms linked to depression via oxidative stress and neuroprogression.
Nataliia Bakunina, Carmine M Pariante, Patricia A Zunszain. Immunology 2015
163
8


Oxidative Stress and the Central Nervous System.
Samina Salim. J Pharmacol Exp Ther 2017
315
8

Cyclooxygenase-2 inhibition reduces stress-induced affective pathology.
Joyonna Carrie Gamble-George, Rita Baldi, Lindsay Halladay, Adrina Kocharian, Nolan Hartley, Carolyn Grace Silva, Holly Roberts, Andre Haymer, Lawrence J Marnett, Andrew Holmes,[...]. Elife 2016
31
8

Markers of Oxidative Stress and Neuroprogression in Depression Disorder.
Magdaléna Vaváková, Zdeňka Ďuračková, Jana Trebatická. Oxid Med Cell Longev 2015
125
8

Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II Depression: A Randomized Clinical Trial.
Roger S McIntyre, Mehala Subramaniapillai, Yena Lee, Zihang Pan, Nicole E Carmona, Margarita Shekotikhina, Joshua D Rosenblat, Elisa Brietzke, Joanna K Soczynska, Victoria E Cosgrove,[...]. JAMA Psychiatry 2019
66
8

The new field of 'precision psychiatry'.
Brisa S Fernandes, Leanne M Williams, Johann Steiner, Marion Leboyer, André F Carvalho, Michael Berk. BMC Med 2017
162
8

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
A John Rush, Madhukar H Trivedi, Stephen R Wisniewski, Andrew A Nierenberg, Jonathan W Stewart, Diane Warden, George Niederehe, Michael E Thase, Philip W Lavori, Barry D Lebowitz,[...]. Am J Psychiatry 2006
8

Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder.
Rita Haapakoski, Julia Mathieu, Klaus P Ebmeier, Harri Alenius, Mika Kivimäki. Brain Behav Immun 2015
472
8

IL-1β, IL-6, TNF- α and CRP in Elderly Patients with Depression or Alzheimer's disease: Systematic Review and Meta-Analysis.
Ada Ng, Wilson W Tam, Melvyn W Zhang, Cyrus S Ho, Syeda F Husain, Roger S McIntyre, Roger C Ho. Sci Rep 2018
129
8

The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder.
Piotr Gałecki, Elżbieta Gałecka, Michael Maes, Marcelina Chamielec, Agata Orzechowska, Kinga Bobińska, Andrzej Lewiński, Janusz Szemraj. J Affect Disord 2012
83
8

The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis.
Jonas Hannestad, Nicole DellaGioia, Michael Bloch. Neuropsychopharmacology 2011
552
8

Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies.
Amirhossein Modabbernia, Shervin Taslimi, Elisa Brietzke, Mandana Ashrafi. Biol Psychiatry 2013
339
8

Danger Signals and Inflammasomes: Stress-Evoked Sterile Inflammation in Mood Disorders.
Monika Fleshner, Matthew Frank, Steven F Maier. Neuropsychopharmacology 2017
89
8


COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex.
W E Kaufmann, P F Worley, J Pegg, M Bremer, P Isakson. Proc Natl Acad Sci U S A 1996
511
8


Prostaglandins and cyclooxygenases in glial cells during brain inflammation.
Shun-Fen Tzeng, Han-Yun Hsiao, Oi-Tong Mak. Curr Drug Targets Inflamm Allergy 2005
83
8

NSAIDs are associated with lower depression scores in patients with osteoarthritis.
Rupa L Iyengar, Sumeet Gandhi, Ashish Aneja, Kevin Thorpe, Louai Razzouk, Jeffery Greenberg, Serge Mosovich, Michael E Farkouh. Am J Med 2013
50
8

The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression.
Michael Maes, Raz Yirmyia, Jens Noraberg, Stefan Brene, Joe Hibbeln, Giulia Perini, Marta Kubera, Petr Bob, Bernard Lerer, Mario Maj. Metab Brain Dis 2009
562
8

Celecoxib enhances the effect of reboxetine and fluoxetine on cortical noradrenaline and serotonin output in the rat.
Daniella Johansson, Aki Falk, Monica M Marcus, Torgny H Svensson. Prog Neuropsychopharmacol Biol Psychiatry 2012
38
8


Integrating neuroimmune systems in the neurobiology of depression.
Eric S Wohleb, Tina Franklin, Masaaki Iwata, Ronald S Duman. Nat Rev Neurosci 2016
263
8

Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness.
Michael Berk, Olivia Dean, Hemmo Drexhage, John J McNeil, Steven Moylan, Adrienne O'Neil, Christopher G Davey, Livia Sanna, Michael Maes. BMC Med 2013
111
8

Inhibition of COX-2 by celecoxib enhances glucocorticoid receptor function.
F Hu, X Wang, T W W Pace, H Wu, A H Miller. Mol Psychiatry 2005
52
8

Eicosanoids Derived From Arachidonic Acid and Their Family Prostaglandins and Cyclooxygenase in Psychiatric Disorders.
Kunio Yui, George Imataka, Hiroyuki Nakamura, Naoki Ohara, Yukiko Naito. Curr Neuropharmacol 2015
40
8




Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.